Thymosin Alpha-1
Thymalfasin
Thymosin Alpha-1 (trade name Zadaxin / Thymalfasin) is a 28 amino acid thymic peptide naturally produced by the thymus gland. It is approved in more than 35 countries for hepatitis B and C treatment, and as an immune adjuvant for vaccines and certain cancers. Research has focused on T-cell maturation, dendritic cell activation, NK cell function, and cytokine modulation of innate and adaptive immune responses. Research dosing is typically 1.6–3.2mg subcutaneously twice weekly in 4–8 week cycles. Researchers track WBC, CD4/CD8 ratio, NK cells, and full immunoglobulin panels (IgG, IgA, IgM) as the primary response biomarkers.
Typical dose
1.6mg
Cycle
4-8 weeks